Delisting risk
KALA BIO
Evaluates biotech AI infrastructure while preserving biologics assets for potential partners.
$0.6902
After-hours close+0.00 (+0.01%)
At close$0.6901(−15.02%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 0.18%34.0K sharesInsiders 0.03%6.3K sharesOther 99.79%19.30M shares
Shares outstanding 19.34M · Float 18.59M · 96.1% free float
Institutions13F, as of Mar 31, 2026
26 holders · 34.0K shares · 8 new positions · 16 increased · 2 reduced · 10 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Renaissance Technologies LLC | 8.4K | 0.04% | +7.5K | May 14, 2026 |
| Citadel Advisors LLC | 5.6K | 0.03% | +4.5K | May 15, 2026 |
| Geode Capital Management, LLC | 5.2K | 0.03% | +4.0K | May 15, 2026 |
| Virtu Financial LLC | 3.0K | 0.02% | +1.3K | May 14, 2026 |
| Adar1 Capital Management, LLC | 2.8K | 0.01% | 0 | May 18, 2026 |
| Gsa Capital Partners LLP | 1.7K | 0.01% | +1.7Knew | May 8, 2026 |
| UBS Group AG | 1.3K | 0.01% | +859 | May 5, 2026 |
| Vanguard Capital Management LLC | 1.2K | 0.01% | +1.2Knew | May 15, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Oxford Finance LLC | 16.50% | 13G | Dec 3, 2025 ↗ | |
| Baker Bros. Advisors LP | 9.99% | 13G | Feb 17, 2026 ↗ | |
| Baker Bros. Advisors (GP) LLCincl. Felix J. Baker, Julian C. Baker +1 more | 9.99% | 13D | Oct 2, 2025 ↗ | |
| ADAR1 Capital Management GP, LLCincl. ADAR1 Capital Management, LLC, Daniel Schneeberger | 9.99% | 13G | Nov 14, 2024 ↗ | |
| LifeSci Capital LLC | 7.90% | 13G | Jan 13, 2026 ↗ | |
| David E. Lazar | 5.18% | 13D | Feb 6, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Oxford Finance LLC | 10 percent owner | 32.4K | 0.17% | Dec 3, 2025 |
| Mark T. Iwicki | director | 2.1K | 0.01% | Oct 24, 2025 |
| Baker Bros. Advisors LP | other: Former 10% owner | 930 | 0.00% | Oct 2, 2025 |
| Darius Kharabi | officer: CHIEF BUSINESS OFFICER | 835 | 0.00% | Oct 24, 2025 |
| Todd Bazemore | director | 719 | 0.00% | Oct 24, 2025 |
| Romulus K. Brazzell | officer: SEE REMARKS | 719 | 0.00% | Oct 24, 2025 |
| Mary Reumuth | officer: CHIEF FINANCIAL OFFICER | 578 | 0.00% | Oct 24, 2025 |
| Andrew I. Koven | director | 339 | 0.00% | Jun 17, 2025 |
| Howard B. Rosen | director | 325 | 0.00% | Jun 17, 2025 |
| Gregory D. Perry | director | 267 | 0.00% | Jun 17, 2025 |
8 ten-percent owners hold 45.0K shares by Form 4 — the 13D/G table above shows those stakes, the figure above counts officers and directors only · 8 people have not refiled in the last 18 months (9.0K shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Oct 22, 2025 | Darius Kharabiofficer: CHIEF BUSINESS OFFICER | Sale | 20,806 | $0.8300 | 41,760 |
| Oct 22, 2025 | Romulus K. Brazzellofficer: SEE REMARKS | Sale | 46,748 | $0.8300 | 35,952 |
| Oct 22, 2025 | Todd Bazemoredirector | Sale | 47,768 | $0.8300 | 35,932 |
| Oct 23, 2025 | Mary Reumuthofficer: CHIEF FINANCIAL OFFICER | Sale | 967 | $0.8200 | 28,906 |
| Oct 22, 2025 | Mary Reumuthofficer: CHIEF FINANCIAL OFFICER | Sale | 32,230 | $0.8300 | 29,873 |
| Oct 23, 2025 | Mark T. Iwickidirector | Sale | 154,894 | $0.8100 | 103,540 |
| Oct 1, 2025 | Baker Bros. Advisors LPother: Former 10% owner | Sale · 2 lots | 513,607 | $1.38 | 46,480 |
| Sep 30, 2025 | Baker Bros. Advisors LPother: Former 10% owner | Sale · 2 lots | 216,801 | $1.60 | 97,120 |
CongressHouse and Senate disclosures
Not reported.